Scorpion bite antidote okayed.
The agency approved the first treatment for scorpion stings. The antidote, Anascorp, was specifically approved for the treatment of stings by the Cen-truroid.es scorpion, also called the bark scorpion. Centruroid.es are found primarily in the Southwest and are the most common scorpions in the United States. Poison centers in Arizona document 11,000 scorpion stings every year, according to the Arizona Poison and Drug Information Center.
Researchers in Mexico developed Anascorp from horse plasma. In a placebo-controlled, double-blind study of 15 children with scorpion sting symptoms, researchers observed that participants who took Anascorp were symptom-free within 4 hours. In comparison, children with severe symptoms usually spend several days in an ICU. Rare Disease Therapeutics will market the drug to health care facilities in areas where bark scorpions are found, such as parts of Arizona, New Mexico, and Nevada.
--From staff reports
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||NEWS FROM THE FDA|
|Publication:||Internal Medicine News|
|Article Type:||Brief article|
|Date:||Sep 15, 2011|
|Previous Article:||TNF blockers tied to infections.|
|Next Article:||Study adds fuel to the mammography debate: experts say the appropriate age for starting screening mammography remains controversial.|